Rising prevalence of cancer and anemia to drive the Global Hematopoietic Stem Cells Transplantation Market

According to a recently published report by Brisk Insights, the Global Hematopoietic Stem Cells Transplantation Market is expected to grow at the CAGR of 10.4 % during 2017-2025. The global hematopoietic stem cells transplantation market is segmented on the basis of application, transplant type, and geography. The report on global hematopoietic stem cells transplantation market (by application, transplant type, and geography) provides a detailed overview and predictive analysis of the market.

Full report available on Hematopoietic Stem Cells Transplantation Market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/hematopoietic-stem-cells-transplantation-market

Market Insights

Increasing prevalence of cancer and anemia in both developed and developing nations are the key growth factors in the hematopoietic stem cells transplantation market. In base year 2016, lymphoproliferative disorders and leukemia accounted for more than 50% of the market share. According to cancer research UK, leukemia is the 11th most common cancer worldwide which represented 2% of total cancer cases. Autologous HSCT has been preferred over allogeneic HSCT due to absence of risk of graft versus host disease. The hematopoietic stem cells transplantation market is currently dominated by North America due to increasing number of patients suffering with cancer and blood disorders, rising public awareness, and supportive reimbursement policies. On the other hand, Asia-Pacific is anticipated to be the fastest growing market because of early disease diagnosis and treatment, increasing prevalence of blood disorders, medical tourism, and developing healthcare infrastructure. 

Scope of the report

1. Global Hematopoietic Stem Cells Transplantation Market, By Application, 2015–2025 ($ Million)

1.1. Leukemia
1.2. Lymphoproliferative Disorders
1.3. Solid Tumors
1.4. Non-malignant Disorders

2. Global Hematopoietic Stem Cells Transplantation Market, By Transplant Type, 2015–2025 ($ Million)

2.1. Autologous Transplant
2.2. Allogeneic Transplant

3. Global Hematopoietic Stem Cells Transplantation Market, By Geography, 2015-2025 ($ Million)

3.1. North America
3.1.1. U.S.
3.1.2. Canada
3.2. Europe
3.2.1. U.K.
3.2.2. Germany
3.2.3. Rest of Europe
3.3. Asia Pacific
3.3.1. Japan
3.3.2. China
3.3.3. Rest of Asia Pacific
3.4. Latin America
3.4.1. Mexico
3.4.2. Brazil
3.4.3. Rest of Latin America
3.5. Middle East and Africa
3.5.1. GCC
3.5.2. Rest of Middle East and Africa

4. Company Profiles

4.1. CellGenix Technologie Transfer GmbH
4.2. Cesca Therapeutics Inc.
4.3. Escape Therapeutics
4.4. Genlantis
4.5. Kite Pharma Inc.
4.6. Lonza Group
4.7. PromoCell GmbH
4.8. Pluristem Therapeutics Inc.
4.9. R&D Systems
4.10. ScienCell Research Laboratories
4.11. Stempuetics Research Pvt. Ltd.
4.12. Takara Bio
4.13. Thermo Fisher Scientific, Inc.
4.14. TiGenix N.V.